semaglutide shortage update FDA Ends Listing, Contributing to Ongoing Legal Challenges Compounded GLP-1 Medications: What’s Changing

#LucidQuest #PharmaCI To view or add a comment, sign in New weight loss drug FDA approves first oral GLP-1 drug for obesity: The FDA has approved Novo Nordisk's oral semaglutide for obesity, making it the first GLP-1 pill for weight loss

Accessed 2/2/2022, Krull KR

doi: 10.2337/dc17-2280

GLP-1 agonists have been used to treat type 2 diabetes for about two decades

Contrave vs Ozempic Cost 2026 Cost is often a deciding factor when choosing between weight loss medications

Future research will have to focus on developing areas such as formalizing procedures, ensuring safety protocols, and establishing reliable stool banks